The present invention relates to microfluidic devices. In particular, the present invention relates to microfluidic devices for performing spatio-temporal operations and applications thereof.
Despite the advantages that microfluidics provides in terms of lower material consumption, faster reaction times, multiplexing, and ability to provide physiological cell culture microenvironments, widespread use of microfluidic circuitry in the lab and clinic are still limited. One of the challenges is that unlike electronic systems where the controller and actuator circuits are all electrical current driven, current microfluidics require electrical circuitry in addition to fluid flow for control and actuation when performing complex functions. This inevitably complicates overall device architecture by the need for integration, alignment, and interfacing of electrical components, actuators, and power sources with the microfluidics components. What would benefit practical system construction is the development of logic-embedded microfluidic circuitry where all of the system controllers as well as actuators are fluid flow driven (for example by using compressed gas). The difficulty to create such a system is that embedded logic requires integration of multiple non-linearly responding components whereas low Reynolds number microfluidic systems are typically linear in their response.
What is needed are simple systems that operate with minimal or no logical input.
The present invention relates to microfluidic devices. In particular, the present invention relates to microfluidic devices for performing spatio-temporal operations and applications thereof.
In some embodiments, the present invention provides a system, comprising: one or more microfluidics devices, wherein each of the microfluidic devices comprises two or more segmented species-containing channels, where the pressure of the species joins or segments the channels; and fluid for regulating the microfluidic devices in the absence of external control. In some embodiments, the species are pressurized from at least one source with a pressure source selected from constant pressure, variable pressure, constant flow rate, or variable flow rate. In some embodiments, the segmentation is selected from the group consisting of a physical barrier, a chemical barrier, and an entropic barrier. In some embodiments, the species are solids, liquids, or gases. In some embodiments, the channels are voids in solid or semi-solid material. In some embodiments, the segmentation is coupled with an interfacing hole or holes to additional layers. In some embodiments, the segmentation comprises one or more valves, and wherein the device is capable of performing fluidic operations in the absence of external control. In some embodiments, the valves are two-way-valves, check-valves, capacitor-like valves or transistor-like-valves. In some embodiments, the system further comprises reagents for point of care applications (e.g., intravenous administration of fluids to a patient or intravenous administration of medication to a patient), reagents for diagnostic assays (e.g., immunoassays), reagents for research applications (e.g., drug screening assays, stem cell culture, protein function assays, or protein crystallization studies), or reagents for industrial applications. In some embodiments, the system further comprises a computer processor in contact with the devices, wherein the computer processor is configured to direct the operations of the devices. In some embodiments, the devices are configured to perform pulsatile fluidic operations. In some embodiments, the system is fully functional in the absence of electricity. In some embodiments, the channels are voids in elastomeric materials. In some embodiments, the segmentation is a physical barrier of elastomeric material. In some embodiments, the species are Newtonian fluids. In some embodiments, separated channels are joined by bypassing segmentation via elastic deformation into surroundings or void in substrate. In some embodiments, joined channels are separated via elastic deformation against the segmentation. In some embodiments, the pressure source is selected from compressed solid, liquid, gas, mechanically driven, or gravity driven.
Embodiments of the present invention further provide a method of performing microfluidic operations, comprising: contacting one or more microfluidics devices, wherein each of the microfluidic devices comprises two or more segmented species-containing channels, where the pressure of the species joins or segments the channel with a fluid for regulating the microfluidic devices in the absence of external control under conditions such that the device performs microfluidic operations using the fluids. In some embodiments, the species are pressurized from at least one source with a pressure source selected from constant pressure, variable pressure, constant flow rate, or variable flow rate. In some embodiments, the segmentation is selected from the group consisting of a physical barrier, a chemical barrier, and an entropic barrier. In some embodiments, the species are solids, liquids, or gases. In some embodiments, the channels are voids in solid or semi-solid material. In some embodiments, the segmentation is coupled with an interfacing hole or holes to additional layers. In some embodiments, the segmentation comprises one or more valves, and wherein the device is capable of performing fluidic operations in the absence of external control. In some embodiments, the valves are two-way-valves, check-valves, capacitor-like valves or transistor-like-valves. In some embodiments, the method performs an application including, but not limited to point of care applications (e.g., intravenous administration of fluids to a patient or intravenous administration of medication to a patient), diagnostic assays (e.g., immunoassays), research applications (e.g., drug screening assays, stem cell culture, protein function assays, or protein crystallization studies), or industrial applications. In some embodiments, a computer processor in contact with the devices directs the operations of the devices. In some embodiments, the devices are configured to perform pulsatile fluidic operations. In some embodiments, the method is performed in the absence of electricity. In some embodiments, the channels are voids in elastomeric materials. In some embodiments, the segmentation is a physical barrier of elastomeric material. In some embodiments, the species are Newtonian fluids. In some embodiments, separated channels are joined by bypassing segmentation via elastic deformation into surroundings or void in substrate. In some embodiments, joined channels are separated via elastic deformation against the segmentation. In some embodiments, the pressure source is selected from compressed solid, liquid, gas, mechanically driven, or gravity driven.
Additional embodiments are described herein.
To facilitate an understanding of the present invention, a number of terms and phrases are defined below:
The term “sample” in the present specification and claims is used in its broadest sense. On the one hand it is meant to include a specimen or culture. On the other hand, it is meant to include both biological and environmental samples. A sample may include a specimen of synthetic origin.
Biological samples may be animal, including human, fluid, solid (e.g., stool) or tissue, as well as liquid and solid food and feed products and ingredients such as dairy items, vegetables, meat and meat by-products, and waste. Biological samples may be obtained from all of the various families of domestic animals, as well as feral or wild animals, including, but not limited to, such animals as ungulates, bear, fish, lagamorphs, rodents, etc.
Environmental samples include environmental material such as surface matter, soil, water and industrial samples, as well as samples obtained from food and dairy processing instruments, apparatus, equipment, utensils, disposable and non-disposable items. These examples are not to be construed as limiting the sample types applicable to the present invention.
As used herein, the term “cell” refers to any eukaryotic or prokaryotic cell (e.g., bacterial cells such as E. coli, yeast cells, mammalian cells, avian cells, amphibian cells, plant cells, fish cells, and insect cells), whether located in vitro or in vivo.
As used herein, the term “cell culture” refers to any in vitro culture of cells. Included within this term are continuous cell lines (e.g., with an immortal phenotype), primary cell cultures, transformed cell lines, finite cell lines (e.g., non-transformed cells), and any other cell population maintained in vitro.
As used, the term “eukaryote” refers to organisms distinguishable from “prokaryotes.” It is intended that the term encompass all organisms with cells that exhibit the usual characteristics of eukaryotes, such as the presence of a true nucleus bounded by a nuclear membrane, within which lie the chromosomes, the presence of membrane-bound organelles, and other characteristics commonly observed in eukaryotic organisms. Thus, the term includes, but is not limited to such organisms as fungi, protozoa, and animals (e.g., humans).
As used herein, the term “in vitro” refers to an artificial environment and to processes or reactions that occur within an artificial environment. In vitro environments can consist of, but are not limited to, test tubes and cell culture. The term “in vivo” refers to the natural environment (e.g., an animal or a cell) and to processes or reaction that occur within a natural environment.
“Purified polypeptide” or “purified protein” or “purified nucleic acid” means a polypeptide or nucleic acid of interest or fragment thereof which is essentially free of, e.g., contains less than about 50%, preferably less than about 70%, and more preferably less than about 90%, cellular components with which the polypeptide or polynucleotide of interest is naturally associated.
The term “isolated” means that the material is removed from its original environment (e.g., the natural environment if it is naturally occurring). For example, a naturally-occurring polynucleotide or polypeptide present in a living animal is not isolated, but the same polynucleotide or DNA or polypeptide, which is separated from some or all of the coexisting materials in the natural system, is isolated. Such polynucleotide could be part of a vector and/or such polynucleotide or polypeptide could be part of a composition, and still be isolated in that the vector or composition is not part of its natural environment.
“Purified product” refers to a preparation of the product which has been isolated from the cellular constituents that the product is normally associated and from other types of cells which may be present in the sample of interest.
The terms “test compound” and “candidate compound” refer to any chemical entity, pharmaceutical, drug, and the like that is a candidate for use to treat or prevent a disease, illness, sickness, or disorder of bodily function. Test compounds comprise both known and potential therapeutic compounds. A test compound can be determined to be therapeutic by screening using the screening methods of the present invention. In some embodiments of the present invention, test compounds include antisense, siRNA or shRNA compounds.
As used herein, the term “processor” refers to a device that performs a set of steps according to a program (e.g., a digital computer). Processors, for example, include Central Processing Units (“CPUs”), electronic devices, or systems for receiving, transmitting, storing and/or manipulating data under programmed control.
As used herein, the term “memory device,” or “computer memory” refers to any data storage device that is readable by a computer, including, but not limited to, random access memory, hard disks, magnetic (floppy) disks, compact discs, DVDs, magnetic tape, flash memory, and the like.
The present invention relates to microfluidic devices. In particular, the present invention relates to microfluidic devices for performing spatio-temporal operations and applications thereof.
Unlike modern electronic systems where the controller and actuator circuits are all electrically driven, microfluidics currently requires peripheral electromechanical components for control and actuation of fluid flow (Pennathur, Lab Chip, 8, 383-387 (2008); Unger et al., Science 288, 113-116 (2000); Gu et al., Proc. Natl. Acad. Sci. USA 101, 15861-15866 (2004)). This more closely resembles the very early days of electrical circuitry where electromechanical relays performed electrical switching. There has been work in using two-phase flow interactions to regulate the movement of bubbles/droplets in order to perform logical operations which can direct the trailing pressurized fluid on-chip (Prakash et al., Science 315, 832-835 (2007); Cheow et al., Appl. Phys. Lett. 90, (2007)). This approach enables high-speed digital flow control, where the bubble/droplet represents a bit of information passing through logic gates, which can be useful for facilitating a multitude of chemical reactions requiring a set of sequential mixing steps. Although this approach can be very powerful for high-throughput droplet assays, this approach is not suitable for a significant portion of microfluidic research which deals with precisely regulating fluids to be exposed to or interact with other physical objects (i.e. microbeads (Lee et al., Science 16, 1793-1796 (2005), cells (Irimia et al., Lab Chip 6, 191-198 (2006), antibodies (Fan et al., Nature Biotech 26, 1373-1378 (2008)). In addition, the bubble/droplet approach requires dynamic input (dictating when bubbles/droplets should be created) in order to perform time-varying operations, which requires external controllers. Another approach, which aims to minimize the need for external control while providing on-chip regulation of fluid flow, is the use of embedded elastomeric valves with tuned resonant frequencies that respond passively according to the frequency of external inputs (Leslie D. C., et al. Frequency-specific flow control in microfluidic circuits with passive elastomeric features. Nature Physics 5, 231-235 (2009)). However, due to the large bandwidth of each component's resonant response, clean switching between different gates using different frequency external actuation is not achievable (Stone, Nature Physics 5, 178-179 (2009)). In addition, currently there is no scheme for different fluids to regulate each other in either a cascading or feedback mechanism.
Control in a cascading electrical or fluidic circuit is dictated by two parameters, a switching mechanism and a time delay. In the methods of embodiments of the present invention, the switching action is facilitated by check-valves and switch-valves that have geometrically defined threshold pressures. These components translate a constant infusion of fluid into a transient outflow. The steady infusion of fluid gradually pressurizes the compliant component until it discharges the pressure upon opening; this process mimics the time-delay effect of a charging capacitor.
Methods have been developed to overcome the non-linearity obstacle to perform fluidic-logic in a microfluidic platform. These systems are limited in applicability due to requirements for specialized polymer solutions, external electronic actuation to form bubbles, precise positioning of multiple droplets of different volumes onto a chip or by the limited non-linearity of the device response. Embodiments of the present invention provide a simple substrate architecture and scalable substrate processing methods that enables integration of multiple non-linearly responsive microfluidic components.
In some embodiments, the present invention provides microfluidics devices for use in performing fluidic-logic, biochemical and industrial applications. The devices may be constructed of any suitable material. Exemplary, non-limiting examples of microfluidic devices are described below. In some embodiments, the devices comprise multiple segmented species-containing channels (e.g., valves), where the pressure of the species joins or segments the channels. In some embodiments, species (e.g., fluids or pressure) are used to regulate the opening or closing of the channels.
In some embodiments, devices are made by the sandwiching of three layers (e.g., poly-dimethylsiloxane (PDMS) layers). In some embodiments, the top and bottom layers contain the main network of microfluidic channels. The middle layer is a thin membrane.
In some embodiments, layers are made by supplying a negative “master” and casting a castable material over the master. Castable materials include, but are not limited to, polymers, including epoxy resins, curable polyurethane elastomers, polymer solutions (e.g., solutions of acrylate polymers in methylene chloride or other solvents), curable polyorganosiloxanes, and polyorganosiloxanes which predominately bear methyl groups (e.g., polydimethylsiloxanes (“PDMS”)). Curable PDMS polymers are well known and available from many sources. Both addition curable and condensation-curable systems are available, as also are peroxide-cured systems. All these PDMS polymers have a small proportion of reactive groups which react to form crosslinks and/or cause chain extension during cure. Both one part (RTV-1) and two part (RTV-2) systems are available. Additional curable systems are preferred when biological particle viability is needed.
In some embodiments, transparent devices are desirable. Such devices may be made of glass or transparent polymers. PDMS polymers are well suited for transparent devices. A benefit of employing a polymer which is slightly elastomeric is the case of removal from the mold and the potential for providing undercut channels, which is generally not possible with hard, rigid materials. Methods of fabrication of microfluidic devices by casting of silicone polymers are well known. See, e.g. D. C. Duffy et al., “Rapid Prototyping of Microfluidic Systems in Poly(dimethylsiloxane),” Analytical Chemistry 70, 4974-4984 (1998). See also, J. R. Anderson et al., Analytical Chemistry 72, 3158-64 (2000); and M. A. Unger et al., Science 288, 113-16 (2000), each of which is herein incorporated by reference in its entirety.
In some embodiments, fluids are supplied to the device by any suitable method. Fluids may, for example, be supplied from syringes, from microtubing attached to or bonded to the inlet channels, etc.
Fluid flow may be established by any suitable method. For example, external micropumps suitable for pumping small quantities of liquids are available. Micropumps may also be provided in the device itself, driven by thermal gradients, magnetic and/or electric fields, applied pressure, etc. All these devices are known to the skilled artisan. Integration of passively-driven pumping systems and microfluidic channels has been proposed by B. H. Weigl et al., Proceedings of MicroTAS 2000, Enshede, Netherlands, pp. 299-302 (2000).
In other embodiments, fluid flow is established by a gravity flow pump, by capillary action, or by combinations of these methods. A simple gravity flow pump consists of a fluid reservoir either external or internal to the device, which contains fluid at a higher level (with respect to gravity) than the respective device outlet. Such gravity pumps have the deficiency that the hydrostatic head, and hence the flow rate, varies as the height of liquid in the reservoir drops. For many devices, a relatively constant and non-pulsing flow is desired.
To obtain constant flow, a gravity-driven pump as disclosed in published PCT application No. WO 03/008102 A1 (Jan. 18, 2002), herein incorporated by reference, may be used. In such devices, a horizontal reservoir is used in which the fluid moves horizontally, being prevented from collapsing vertically in the reservoir by surface tension and capillary forces between the liquid and reservoir walls. Since the height of liquid remains constant, there is no variation in the hydrostatic head.
Flow may also be induced by capillary action. In such a case, fluid in the respective outlet channel or reservoir will exhibit greater capillary forces with respect to its channel or reservoir walls as compared to the capillary forces in the associated device. This difference in capillary force may be brought about by several methods. For example, the walls of the outlet and inlet channels or reservoirs may have differing hydrophobicity or hydrophilicity. Alternatively, the cross-sectional area of the outlet channel or reservoir is made smaller, thus exhibiting greater capillary force.
In some embodiments, flow is facilitated by embedded capacitor valves that pump fluids in a separate channel when pressurized. This is achieved by having a series of valves in the bottom that direct a pressurized gas or liquid causing the membrane to deform and squeeze the fluid in the top channel forward. Additional control is provided by having valves in the top layer that can open sequentially.
In some embodiments, a fluidic system comprising valves and channels is built to perform a particular task. Usually this means a certain number of valves need to be operated, for example, opened or closed, in a particular sequence, and possibly for different durations, in order to accomplish the desired task.
One advantage of the systems and methods of embodiments of the present invention is the auto-regulatory role of the components and the ability to incorporate them in large scale both in parallel and in series. This advantage allows complex operations to be performed with little external setup or signaling. For cases where a pre-defined operation is desired without any variable decisions, this system enables all functionality to be completely encoded into the device (that is no external electrical, pneumatic, or mechanical input is required except for the source of fluid flow). This allows users with little training to operate the devices. Therefore, in some embodiments, the systems and methods described herein are amenable for point-of-care applications, diagnostic tests, and assays for non-microfluidic specialists in academic or industrial labs. For assays which require a specific sequence and ratio of mixing of solutions (e.g., immunoassays/drug screenings/crystallization studies), the systems described herein can perform the assays automatically with the user only needing to activate the device.
However, some assays require a variable input from the user to which the device then subsequently performs a particular operation. In this case, it is preferred to have some kind of logical control over the device's operations. The systems described herein enable logical operations to be performed by reconfiguring the geometry through input signals from the user that can either open or close transistor-valves. An example would be the metering of solutions based on a patient's weight. The device can have several inputs for different weight ranges which respectively activate a separate set of components which will deliver different amounts of solutions.
Many cells and biological systems respond to the same chemical or set of chemicals differently depending on spatio-temporal pattern of administration of the drug or biochemical.
For example, insulin is released in a pulsatile manner in the body; some bacteria grow better when provided with nutrients in waves rather than constantly or in a onetime bolus; G-protein coupled receptor (GPCR) signaling can be very different depending on the temporal pattern of ligand delivery to cells. This capability can be used to determine signaling mechanisms as well as potentially regulate cell behavior. Thus the ability of the embedded fluidic circuits to provide various pulsed patterns of chemicals to cells has important applications in stem cell proliferation and differentiation, in determining signaling mechanisms, and in optimizing bioreactor production, etc. The small size and multiplexing capabilities especially are useful for screening many different temporal patterns of chemical exposure on cells in parallel to identify ideal conditions for culture, differentiation, mechanistic evaluations.
Another advantage of the systems and methods of embodiments of the present invention are their ability to compartmentalize fluids in an unpressurized state, providing a means for device memory. Therefore assays can be conducted which provide several output solutions which can be stored and segregated from other fluids by negating any flow or diffusion of molecules which could cross-contaminate the solutions. For example, in some embodiments, a sample of blood that contains unstable proteins is taken from a patient. Those proteins are then be immediately processed by the device and provide a preliminary diagnosis while also being stored in a stable solution so that testing can be performed later in a lab if needed. This feature is particularly useful for point-of-care applications where there could be a long distance from the ground site and the testing lab which is expensive and inconvenient to have patients unnecessarily travel.
The devices, system and method of the present invention find use in a variety of applications including, but not limited to, point of care diagnostics (e.g., field assays and tests, especially where electrical power sources are not available or where electrical circuits might not be durable (e.g., in space or nuclear power plants)); mechanistic studies, bioreactor optimization, stem cell culture, and crystallization studies.
Additional applications of microfluidic devices include, but are not limited to, chemical and biochemical sensing systems, protein and chemical synthesis, and spectroscopy of ultra-small volumes. Depending on the application, the microfluidic devices of the invention can provide as output fluidic logic signals, processed materials (e.g., such as micro- or nano-quantities of chemicals or other substances), or information about the materials that are processed, such as the results of diagnostic tests, that can be of significance for a user.
The following examples are provided in order to demonstrate and further illustrate certain preferred embodiments and aspects of the present invention and are not to be construed as limiting the scope thereof.
The device consists of three layers made from PDMS prepolymer and curing agent (Sylgard 184, Dow Corning Co., Midland, Mich.) at a 10:1 ratio. The top and bottom layers are molded against a master mold made by standard photolithography using the negative-photoresist SU-8 (SU-8, MicroChem. Co., Newton, Mass.). The master molds were silanized in a desiccator for 2 hours (United Chemical Tech., Bristol, Pa.). The height of all top layer and bottom layer features is 100 μm except for those in
Fabrication of Device with Integrated Components
The three layers of the device are bonded. In the first step, the thin PDMS membrane, while still on the silicon wafer (or any flat substrate), is bonded to either the top or bottom layer and then the two bonded layers are detached from the wafer. Access holes are made in the top layer with a biopsy punch. Holes are punched into the bonded middle layer, using a 350 μm biopsy punch (Ted Pella Inc., Redding, Calif.), for the check-valve and switch-valve components for all figures except
The dependence of threshold pressure on the geometry of a component was characterized for three lengths of both L1 and W (as shown in
All components in the fluidic circuits are made in a three layer polydimethylsiloxane (PDMS) substrate where the top and bottom layers contain patterned channel features and cavities whereas the middle layer is a thin deformable membrane with strategically positioned through-holes (
Integrating components in specific configurations enables pre-defined regulation of fluids. A fundamental fluidic operation, which has only been able to be facilitated by external control, is the continuous switching of single-phase Newtonian fluids.
Creating oscillations on-chip has many implications to signal processing, clock-signal generation, and also biological relevance for applications which utilize cyclic or pulsatile flow.
In addition to oscillations, another useful fluidic control function is the ability to perform an automated sequential operation as done in electronic finite state machines.
As with electronic circuits, one factor for wide-spread use of microfluidic devices is the ability to integrate components in large-scale (
In order to estimate the performance of the developed microfluidic system, a theoretical model based on equivalent fluidic circuit concept was constructed. The underlying fluid model is based on the Navier-Stokes equation and mechanics. There are three basic components: fluid resistance, capacitance, and inductance that are used to derive the model.
Analogous to electrical resistance, fluid resistance is defined as the ratio of pressure drop over flow rate,
where ΔP is the pressure difference, in N/m2, and Q is the volume flow rate, in m3/s. For a microfluidic channel with a rectangular cross section with width w, and depth h, and assuming both-laminar flow and Newtonian fluid, the resistance is
Compliant elements of a fluidic system exhibit the fluidic equivalent of capacitance as a pressure-dependent volume change
The fluidic capacitance for a square membrane can be derived by plate theory as
where w is membrane width, in m, E is Young's modulus of membrane, in N/m2, t is membrane thickness, in m, and v is Poisson's ratio of membrane (dimensionless.)
In a manner analogous to electrical inductance, fluidic systems are capable of storing kinetic energy in fluidic inductance, H (in kg/m4)
For incompressible and inert fluids in tubes of constant cross section A, the fluidic inductance is given by
The switch valve was modelled it as a capacitor between the inlet and the cavity channel, and a switch between the inlet and the outlet (
Since all fluidic components are made within the same three layers, their integration into a single device is highly scalable. The fabrication procedure which selectively deactivates oxidized PDMS layers so that the middle membrane layer does not bond to the part of the PDMS that forms the gap between interrupted channels is useful for such integration (
In summary, this example describes a substrate-architecture, circuit-design principles, and a scalable fabrication process to construct interactive microfluidic flow-controlling component networks. Simple variation of component geometry directly controls its opening threshold pressure enabling control of timing of flow valving and switching. Although the fluidic control demonstrations shown here are simple, electronic circuit analysis describes that every circuit or logic operation is possible using only a transistor component. Since a transistor's directionally distinct switching properties are mimicked by having a switch-valve and check-valve in series, this demonstrates broad applicability of the developed elastomeric components for device embedded flow control.
This Example describes the use of an air-driven device. The capacitance of an elastomer is used to pump fluids in a separate channel when pressurized. This is achieved by having a series of valves in the bottom that direct a pressurized gas or liquid causing the membrane to deform and squeeze the fluid in the top channel forward. Additional control is provided by having valves in the top layer that can open sequentially as previously demonstrated.
All publications and patents mentioned in the above specification are herein incorporated by reference. Various modifications and variations of the described method and system of the invention will be apparent to those skilled in the art without departing from the scope and spirit of the invention. Although the invention has been described in connection with specific preferred embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. Indeed, various modifications of the described modes for carrying out the invention which are obvious to those skilled in electrical engineering, optics, physics, and molecular biology or related fields are intended to be within the scope of the following claims.
This application claims priority to U.S. Provisional Application Ser. No. 61/104,492, filed on Oct. 10, 2008, which is herein incorporated by reference in its entirety.
This invention was made with government support under Grant HL-084370, awarded by the National Institutes of Health. The government has certain rights in the invention.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US2009/055722 | 9/2/2009 | WO | 00 | 6/17/2011 |
Number | Date | Country | |
---|---|---|---|
61104492 | Oct 2008 | US |